Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders

The treatment of various central nervous system (CNS) diseases has been challenging, despite the rapid development of several novel treatment approaches. The blood–brain barrier (BBB) is one of the major issues in the treatment of CNS diseases, having major role in the protection of the brain but si...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadur, Shiv, Pardhi, Dinesh M., Rautio, Jarkko, Rosenholm, Jessica M., Pathak, Kamla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767046/
https://www.ncbi.nlm.nih.gov/pubmed/33352959
http://dx.doi.org/10.3390/pharmaceutics12121230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767046/
https://www.ncbi.nlm.nih.gov/pubmed/33352959
http://dx.doi.org/10.3390/pharmaceutics12121230

Ejemplares similares